Employment, Volunteering, and Health‐Related Resource Use in Anti‐Amyloid in Asymptomatic Alzheimer's Disease (A4) Study

AAIC 2025 Abstract

Abstract

Background: “Pre‐symptomatic” Alzheimer's disease (AD), defined by the presence of brain amyloid in the absence of cognitive symptoms, has been identified as an ideal stage to target for the prevention of progression to cognitive impairment and dementia, but little is known about the health economic impact (including t

The paper

James J. Peters VA Medical Center

AAIC 2025 Abstract · 23 Dec 2025 · CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70860_105779